Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice.
Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice.
复制标题
通过计算机触摸屏验证自动筛查，以实现常规肿瘤学实践。
DOI：
10.1054/bjoc.2001.2182
复制
发表时间：
2001-12-14
影响因子：
8.8
通讯作者：
Selby, P
中科院分区：
文献类型：
--
作者：
Cull, A;Gould, A;House, A;Smith, A;Strong, V;Velikova, G;Wright, P;Selby, P
该研究的目的是确认在常规肿瘤学实践中使用触摸屏计算机筛查癌症患者临床显着痛苦水平的有效性。采用医院焦虑抑郁量表（HADS）、EORTC生活质量问卷（QLQ-C30）、心理健康调查表（MHI 5）和关注问题量表对172例门诊化疗患者进行调查，两次间隔2-4周。在第二次评估的一周内进行标准精神病学访谈（现状检查- PSE）。在访谈中，23%的患者被确定为“病例”。采用现有数据（问卷调查、社会人口统计学细节、自我报告的既往精神病史），最佳筛查策略结合来自单个时间点的MHI-5和HADS评分，并遵循以下规则：如果MHI-5 < 11 =非病例;如果MHI-5 ≥ 11则使用HADS;然后，如果HADS ≥ 9 =“病例”（敏感性85%;特异性71%;错误分类率26%;阳性预测值47%）。计算机化筛查系统能够真实的实时收集、评分、整理和报告数据，以确定需要进一步临床评估的患者。它提供了在常规肿瘤学实践中改善“病例”检测的潜力，同时减少了对“非病例”提出问题的负担。需要进一步开展工作，以制定为此目的筛选问题的最佳选择。© 2001年癌症研究运动http://www.bjcancer.com
The aim of the study was to confirm the validity of using touchscreen computers for screening for clinically significant levels of distress among cancer patients in routine oncology practice. The Hospital Anxiety and Depression Scale (HADS), EORTC Quality of Life questionnaire (QLQ-C30), Mental Health Inventory-MHI5 and a Concerns Checklist were administered via touchscreen computer to 172 chemotherapy out-patients, twice, 2–4 weeks apart. A standard psychiatric interview (Present State Examination – PSE) was conducted within a week of the second assessment. On interview, 23% of patients were identified as ‘cases’. Using the available data (questionnaires, sociodemographic details, self-reported past psychiatric history), the best screening strategy combined scores from MHI-5 and HADS from a single time-point with the following rules: if MHI-5 < 11 = non-case; if MHI-5 ≥ 11 then use HADS; then, if HADS ≥ 9 = ‘case’ (sensitivity 85%; specificity 71%; misclassification rate 26%; positive predictive value 47%). The computerized screening system enabled data to be collected, scored, collated and reported in real time to identify patients who warrant further clinical assessment. It offers the potential for improving ‘case’ detection in routine oncology practice while reducing the burden of questions put to ‘non-cases’. Further work is needed to develop optimal choice of screening questions for this purpose. © 2001 Cancer Research Campaign http://www.bjcancer.com